Remarkable and persistent shrinkage of uterine leiomyoma associated with interferon alfa treatment for hepatitis

Lancet. 1999 Jun 19;353(9170):2127-8. doi: 10.1016/S0140-6736(99)01648-7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Female
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Humans
  • Interferon-alpha / therapeutic use*
  • Leiomyoma / complications
  • Leiomyoma / drug therapy*
  • Uterine Neoplasms / complications
  • Uterine Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Antiviral Agents
  • Interferon-alpha